Aug 5, 2026 10:40AM
Jun 17, 2026 07:00AM
May 3, 2026 01:10PM
May 3, 2026 01:10PM
Apr 17, 2026 02:00PM
Apr 17, 2026 02:00PM
Apr 15, 2026 07:00AM UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at AAN 2026 meeting
Mar 24, 2026 02:46PM
Dec 8, 2025 07:00AM
Dec 8, 2025 07:00AM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Nov 3, 2025 04:00PM
Oct 31, 2025 01:04PM BIMZELX® (bimekizumab-bkzx) Data in Hidradenitis Suppurativa Showed Improvements in Pain and Resolution of Draining Tunnels Sustained to Three Years
Oct 29, 2025 07:00AM
Oct 14, 2025 07:10AM
Sep 17, 2025 07:00AM
Jun 12, 2025 12:30PM
May 19, 2025 12:30PM
Apr 3, 2025 07:00AM
Mar 19, 2025 07:00AM New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference
Mar 12, 2025 01:54PM
Mar 7, 2025 08:00AM
Feb 27, 2025 07:00AM
Jan 16, 2025 07:00AM
Dec 6, 2024 12:00PM
Nov 26, 2024 07:00AM
Nov 20, 2024 07:00AM UCB Receives U.S. FDA Approval for BIMZELX® (bimekizumab-bkzx) as the First IL-17A and IL-17F Inhibitor for Adults with Moderate-to-Severe Hidradenitis Suppurativa
Nov 14, 2024 12:46PM
Sep 23, 2024 07:00AM
Jun 24, 2024 07:00AM
Jun 20, 2024 08:00AM
May 23, 2024 07:00AM
Apr 12, 2024 07:00AM
Apr 4, 2024 07:00AM FDA Accepts Supplemental Biologics License Applications for BIMZELX® (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa and Additional 2mL Device Presentations
Feb 28, 2024 07:03AM
Jan 3, 2024 07:00AM
Dec 2, 2023 07:00AM
Dec 1, 2023 07:00AM
Nov 14, 2023 07:00AM
Nov 1, 2023 07:00AM
Oct 31, 2023 07:00AM NAYZILAM® (midazolam) Results Published in 'Epilepsy & Behavior' Examining the Impact of Dose on Return to Full Baseline Function (RTFBF) for People with Seizure Clusters
Oct 18, 2023 07:00AM
Oct 17, 2023 06:34PM
Oct 13, 2023 12:00PM
Oct 12, 2023 12:20PM
Oct 4, 2023 01:06PM
Jul 21, 2023 07:00AM
Jun 27, 2023 07:00AM UCB announces U.S. FDA approval of RYSTIGGO® (rozanolixizumab-noli) for the treatment of adults with generalized myasthenia gravis
Apr 20, 2023 07:00AM

328,604 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All